Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,206.80
(
-1.14%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.64
(
-1.06%
)
Bitcoin
81,012.22
(
0.65%
)
News Focus
News Focus
Post# of 405212
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biodoc

Send PM Follow Ignore
Followers 60
Posts 595
Boards Moderated 0
Alias Born 08/10/2014

biodoc

Re: BonelessCat post# 78063

Wednesday, 11/12/2014 8:12:40 PM

Wednesday, November 12, 2014 8:12:40 PM

Post# of 405212
With P53/P21 data suggesting a dose response relationship, I'd think they'd be interested in going to more than once per week dosing. Would they accomplish this through a protocol change in Phase 1? Or would they be able to argue a slightly lower dose with greater frequency (allowing for a greater total dose) for a Phase 2 protocol? TIA.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote